Selected research
Market Analysis & Forecast
Global Cinnarizine Market Analysis and Forecast 2026-2032
Market perspective
The global Cinnarizine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cinnarizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cinnarizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cinnarizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cinnarizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cinnarizine include Teva, Johnson And Johnson, Novartis, Mylan, Zambon, Sopharma, Nidda Healthcare, March Pharma and Leti Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cinnarizine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cinnarizine, also provides the sales of main regions and countries. Of the upcoming market potential for Cinnarizine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cinnarizine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cinnarizine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cinnarizine sales, projected growth trends, production technology, application and end-user industry.
Cinnarizine Segment by Company
Teva
Johnson And Johnson
Novartis
Mylan
Zambon
Sopharma
Nidda Healthcare
March Pharma
Leti Pharma
Inga Laboratories
Hasco-Lek
Goodwill Pharma
Gedeon Richter
Eurogenerics
Aurobindo Pharma
Apotex
Allena Pharmaceuticals
Cinnarizine Segment by Type
On-line
Drug Store
Hospital
Cinnarizine Segment by Application
Histamine H₁-Receptor Antagonist
Antiemetic Agent
Antivertigo Agent
Cinnarizine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cinnarizine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cinnarizine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cinnarizine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-line
- Drug Store
- Hospital
Applications
- Histamine H₁-Receptor Antagonist
- Antiemetic Agent
- Antivertigo Agent
Companies covered
- Teva
- Johnson And Johnson
- Novartis
- Mylan
- Zambon
- Sopharma
- Nidda Healthcare
- March Pharma
- Leti Pharma
- Inga Laboratories
- Hasco-Lek
- Goodwill Pharma
- Gedeon Richter
- Eurogenerics
- Aurobindo Pharma
- Apotex
- Allena Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cinnarizine Market by Type
- 1.2.1 Global Cinnarizine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 On-line
- 1.2.3 Drug Store
- 1.2.4 Hospital
- 1.3 Cinnarizine Market by Application
- 1.3.1 Global Cinnarizine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Histamine H₁-Receptor Antagonist
- 1.3.3 Antiemetic Agent
- 1.3.4 Antivertigo Agent
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cinnarizine Market Dynamics
- 2.1 Cinnarizine Industry Trends
- 2.2 Cinnarizine Industry Drivers
- 2.3 Cinnarizine Industry Opportunities and Challenges
- 2.4 Cinnarizine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cinnarizine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cinnarizine Revenue by Region
- 3.2.1 Global Cinnarizine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cinnarizine Revenue by Region (2021-2026)
- 3.2.3 Global Cinnarizine Revenue by Region (2027-2032)
- 3.2.4 Global Cinnarizine Revenue Market Share by Region (2021-2032)
- 3.3 Global Cinnarizine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cinnarizine Sales by Region
- 3.4.1 Global Cinnarizine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cinnarizine Sales by Region (2021-2026)
- 3.4.3 Global Cinnarizine Sales by Region (2027-2032)
- 3.4.4 Global Cinnarizine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cinnarizine Revenue by Manufacturers
- 4.1.1 Global Cinnarizine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cinnarizine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cinnarizine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cinnarizine Sales by Manufacturers
- 4.2.1 Global Cinnarizine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cinnarizine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cinnarizine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cinnarizine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cinnarizine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cinnarizine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cinnarizine Manufacturers, Product Type & Application
- 4.7 Global Cinnarizine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cinnarizine Market CR5 and HHI
- 4.8.2 2025 Cinnarizine Tier 1, Tier 2, and Tier 3
5 Cinnarizine Market by Type
- 5.1 Global Cinnarizine Revenue by Type
- 5.1.1 Global Cinnarizine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cinnarizine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cinnarizine Revenue Market Share by Type (2021-2032)
- 5.2 Global Cinnarizine Sales by Type
- 5.2.1 Global Cinnarizine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cinnarizine Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Cinnarizine Sales Market Share by Type (2021-2032)
- 5.3 Global Cinnarizine Price by Type
6 Cinnarizine Market by Application
- 6.1 Global Cinnarizine Revenue by Application
- 6.1.1 Global Cinnarizine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cinnarizine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cinnarizine Revenue Market Share by Application (2021-2032)
- 6.2 Global Cinnarizine Sales by Application
- 6.2.1 Global Cinnarizine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cinnarizine Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Cinnarizine Sales Market Share by Application (2021-2032)
- 6.3 Global Cinnarizine Price by Application
7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Company Information
- 7.1.2 Teva Business Overview
- 7.1.3 Teva Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Cinnarizine Product Portfolio
- 7.1.5 Teva Recent Developments
- 7.2 Johnson And Johnson
- 7.2.1 Johnson And Johnson Company Information
- 7.2.2 Johnson And Johnson Business Overview
- 7.2.3 Johnson And Johnson Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson And Johnson Cinnarizine Product Portfolio
- 7.2.5 Johnson And Johnson Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novartis Cinnarizine Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Company Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mylan Cinnarizine Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 Zambon
- 7.5.1 Zambon Company Information
- 7.5.2 Zambon Business Overview
- 7.5.3 Zambon Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Zambon Cinnarizine Product Portfolio
- 7.5.5 Zambon Recent Developments
- 7.6 Sopharma
- 7.6.1 Sopharma Company Information
- 7.6.2 Sopharma Business Overview
- 7.6.3 Sopharma Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sopharma Cinnarizine Product Portfolio
- 7.6.5 Sopharma Recent Developments
- 7.7 Nidda Healthcare
- 7.7.1 Nidda Healthcare Company Information
- 7.7.2 Nidda Healthcare Business Overview
- 7.7.3 Nidda Healthcare Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Nidda Healthcare Cinnarizine Product Portfolio
- 7.7.5 Nidda Healthcare Recent Developments
- 7.8 March Pharma
- 7.8.1 March Pharma Company Information
- 7.8.2 March Pharma Business Overview
- 7.8.3 March Pharma Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 March Pharma Cinnarizine Product Portfolio
- 7.8.5 March Pharma Recent Developments
- 7.9 Leti Pharma
- 7.9.1 Leti Pharma Company Information
- 7.9.2 Leti Pharma Business Overview
- 7.9.3 Leti Pharma Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Leti Pharma Cinnarizine Product Portfolio
- 7.9.5 Leti Pharma Recent Developments
- 7.10 Inga Laboratories
- 7.10.1 Inga Laboratories Company Information
- 7.10.2 Inga Laboratories Business Overview
- 7.10.3 Inga Laboratories Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Inga Laboratories Cinnarizine Product Portfolio
- 7.10.5 Inga Laboratories Recent Developments
- 7.11 Hasco-Lek
- 7.11.1 Hasco-Lek Company Information
- 7.11.2 Hasco-Lek Business Overview
- 7.11.3 Hasco-Lek Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Hasco-Lek Cinnarizine Product Portfolio
- 7.11.5 Hasco-Lek Recent Developments
- 7.12 Goodwill Pharma
- 7.12.1 Goodwill Pharma Company Information
- 7.12.2 Goodwill Pharma Business Overview
- 7.12.3 Goodwill Pharma Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Goodwill Pharma Cinnarizine Product Portfolio
- 7.12.5 Goodwill Pharma Recent Developments
- 7.13 Gedeon Richter
- 7.13.1 Gedeon Richter Company Information
- 7.13.2 Gedeon Richter Business Overview
- 7.13.3 Gedeon Richter Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Gedeon Richter Cinnarizine Product Portfolio
- 7.13.5 Gedeon Richter Recent Developments
- 7.14 Eurogenerics
- 7.14.1 Eurogenerics Company Information
- 7.14.2 Eurogenerics Business Overview
- 7.14.3 Eurogenerics Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Eurogenerics Cinnarizine Product Portfolio
- 7.14.5 Eurogenerics Recent Developments
- 7.15 Aurobindo Pharma
- 7.15.1 Aurobindo Pharma Company Information
- 7.15.2 Aurobindo Pharma Business Overview
- 7.15.3 Aurobindo Pharma Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Aurobindo Pharma Cinnarizine Product Portfolio
- 7.15.5 Aurobindo Pharma Recent Developments
- 7.16 Apotex
- 7.16.1 Apotex Company Information
- 7.16.2 Apotex Business Overview
- 7.16.3 Apotex Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Apotex Cinnarizine Product Portfolio
- 7.16.5 Apotex Recent Developments
- 7.17 Allena Pharmaceuticals
- 7.17.1 Allena Pharmaceuticals Company Information
- 7.17.2 Allena Pharmaceuticals Business Overview
- 7.17.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 Allena Pharmaceuticals Cinnarizine Product Portfolio
- 7.17.5 Allena Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Cinnarizine Market Size by Type
- 8.1.1 North America Cinnarizine Revenue by Type (2021-2032)
- 8.1.2 North America Cinnarizine Sales by Type (2021-2032)
- 8.1.3 North America Cinnarizine Price by Type (2021-2032)
- 8.2 North America Cinnarizine Market Size by Application
- 8.2.1 North America Cinnarizine Revenue by Application (2021-2032)
- 8.2.2 North America Cinnarizine Sales by Application (2021-2032)
- 8.2.3 North America Cinnarizine Price by Application (2021-2032)
- 8.3 North America Cinnarizine Market Size by Country
- 8.3.1 North America Cinnarizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cinnarizine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cinnarizine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Cinnarizine Market Size by Type
- 9.1.1 Europe Cinnarizine Revenue by Type (2021-2032)
- 9.1.2 Europe Cinnarizine Sales by Type (2021-2032)
- 9.1.3 Europe Cinnarizine Price by Type (2021-2032)
- 9.2 Europe Cinnarizine Market Size by Application
- 9.2.1 Europe Cinnarizine Revenue by Application (2021-2032)
- 9.2.2 Europe Cinnarizine Sales by Application (2021-2032)
- 9.2.3 Europe Cinnarizine Price by Application (2021-2032)
- 9.3 Europe Cinnarizine Market Size by Country
- 9.3.1 Europe Cinnarizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cinnarizine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cinnarizine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Cinnarizine Market Size by Type
- 10.1.1 China Cinnarizine Revenue by Type (2021-2032)
- 10.1.2 China Cinnarizine Sales by Type (2021-2032)
- 10.1.3 China Cinnarizine Price by Type (2021-2032)
- 10.2 China Cinnarizine Market Size by Application
- 10.2.1 China Cinnarizine Revenue by Application (2021-2032)
- 10.2.2 China Cinnarizine Sales by Application (2021-2032)
- 10.2.3 China Cinnarizine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cinnarizine Market Size by Type
- 11.1.1 Asia Cinnarizine Revenue by Type (2021-2032)
- 11.1.2 Asia Cinnarizine Sales by Type (2021-2032)
- 11.1.3 Asia Cinnarizine Price by Type (2021-2032)
- 11.2 Asia Cinnarizine Market Size by Application
- 11.2.1 Asia Cinnarizine Revenue by Application (2021-2032)
- 11.2.2 Asia Cinnarizine Sales by Application (2021-2032)
- 11.2.3 Asia Cinnarizine Price by Application (2021-2032)
- 11.3 Asia Cinnarizine Market Size by Country
- 11.3.1 Asia Cinnarizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cinnarizine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cinnarizine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cinnarizine Market Size by Type
- 12.1.1 SAMEA Cinnarizine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cinnarizine Sales by Type (2021-2032)
- 12.1.3 SAMEA Cinnarizine Price by Type (2021-2032)
- 12.2 SAMEA Cinnarizine Market Size by Application
- 12.2.1 SAMEA Cinnarizine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cinnarizine Sales by Application (2021-2032)
- 12.2.3 SAMEA Cinnarizine Price by Application (2021-2032)
- 12.3 SAMEA Cinnarizine Market Size by Country
- 12.3.1 SAMEA Cinnarizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cinnarizine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cinnarizine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cinnarizine Value Chain Analysis
- 13.1.1 Cinnarizine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cinnarizine Production Mode & Process
- 13.2 Cinnarizine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cinnarizine Distributors
- 13.2.3 Cinnarizine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst